Olema Pharmaceuticals, Inc. (OLMA) Insider Trading

Name: Olema Pharmaceuticals, Inc. (OLMA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 2, 2026): Jason O'Byrne (CHIEF FINANCIAL OFFICER): Grant/Award of 650,000 shares.

Get alerted when insiders trade OLMA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta